| Tocilizumab in the treatment of severe and/or refractory vasculo-Behcet's disease: a single-centre experience in China | |
| Ding, Yanxia; Li, Chaoran; Liu, Jinjing; Yu, Xin; Wang, Yining; Shi, Jing; Li, Lu; Zhou, Jiaxin; Wang, Li; Chen, Hua | |
| 2018 | |
| 卷号 | 57期号:11页码:2057-2059 |
| ISSN号 | 1462-0324 |
| DOI | 10.1093/rheumatology/key230 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6355503 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Ding, Yanxia,Li, Chaoran,Liu, Jinjing,et al. Tocilizumab in the treatment of severe and/or refractory vasculo-Behcet's disease: a single-centre experience in China[J],2018,57(11):2057-2059. |
| APA | Ding, Yanxia.,Li, Chaoran.,Liu, Jinjing.,Yu, Xin.,Wang, Yining.,...&Zheng, Wenjie.(2018).Tocilizumab in the treatment of severe and/or refractory vasculo-Behcet's disease: a single-centre experience in China.,57(11),2057-2059. |
| MLA | Ding, Yanxia,et al."Tocilizumab in the treatment of severe and/or refractory vasculo-Behcet's disease: a single-centre experience in China".57.11(2018):2057-2059. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论